TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Anti-Tobacco Ads Face Challenge Two groups representing New York City merchants have joined the three biggest U.S. tobacco companies to challenge a requirement that stores place graphic anti-tobacco signs where tobacco products are offered. online.wsj.com |
Move to Repeal Tax Rule Tied to Health Overhaul Fails House Democrats voted in favor of repealing a small part of the health overhaul involving tax-reporting rules, but the repeal move failed to pass because it fell short of the two-thirds support required. online.wsj.com |
Genzyme Shareholder Files Suit to Block Sanofi Deal: Biotech's Latest Mishaps The Burrill Report submits: A Genzyme (GENZ) shareholder has filed suit to prevent the company from entering into an acquisition agreement with Sanofi-Aventis (SNY), The Boston Globe reported. Sanofi reportedly offered $69 a share or $18.4 billion to buy the Cambridge, Massachusetts-based biotech, although neither company has publicly commented on any offer or ongoing negotiations. The suit, filed in Superior Court in Woburn, Massachusetts, charges that selling the company to Sanofi at the price being discussed would be a breach of the Genzyme’s board fiduciary responsibility because it would represent a discount to its true value. The suit seeks class-action status. Eli Lilly (LLY) said it will halt development of its experimental drug to treat Alzheimer’s semagacestat because preliminary results from two ongoing long-term phase 3 studies showed it failed to slow disease progression and was associated with worsening of cognition and the ability to perform activities of daily living. The company said its decision does not affect the ongoing clinical trials of solanezumab, Lilly's other compound in phase 3 trials as a potential Alzheimer's treatment. While both drugs focus on amyloid-beta proteins, which are believed to play a critical role in Alzheimer's disease, they have different mechanisms of action. Lilly also has two other compounds in earlier stages of clinical development; those studies are not affected by the announcement.Complete Story » seekingalpha.com |
FDA to Seek Panel Advice On Anti-Anemia Drugs The FDA will ask another advisory panel for advice on the use of Amgen's Aranesp and similar drugs for patients with chronic kidney disease, in the face of concerns about cardiovascular problems. online.wsj.com |
Wet Ones Healthy Hands Zone Experiment - Video Wet Ones® Antibacterial Hand Wipes and Bill Nye Launch the Wet Ones Healthy Hands Zone™ Website to Educate Families About the Importance of Clean Hands feedproxy.google.com |